PFM
BCTXW

Privium Fund Management’s BriaCell Therapeutics Corp Warrant BCTXW Stock Holding History

Privium Fund Management’s Portfolio BCTXW Stock Details BCTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-64,907
Closed -$159K – 116
2023
Q2 		$159K Sell
64,907
-57,177
-47% -$158K 0.05% 76
2023
Q1 		$361K Sell
122,084
-196,876
-62% -$566K 0.12% 53
2022
Q4 		$622K Buy
318,960
+45,306
+17% +$106K 0.24% 43
2022
Q3 		$710K Buy
273,654
+78,837
+40% +$236K 0.27% 52
2022
Q2 		$507K Buy
+194,817
New +$622K 0.17% 68

Other funds holding BCTXW

AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $17.8B AUM 21.2% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return